Ripple Scores Another Win as SEC Waives “Bad Actor” Rule, Eases Fundraising Limits
Ripple (XRP) has secured one other key victory in its regulatory readability push. The U.S. Securities and Change Fee (SEC) has granted a waiver that removes the corporate’s “dangerous actor”….